Knight Therapeutics Inc.

KHTRF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$3-$13$2$11
Dep. & Amort.$13$12$12$14
Deferred Tax-$0-$3-$3$1
Stock-Based Comp.$0$3$1-$1
Change in WC-$8$13-$12-$12
Other Non-Cash$6$8$4-$11
Operating Cash Flow$8$20$4$1
Investing Activities
PP&E Inv.-$2-$1-$0-$1
Net Acquisitions-$2-$107$0$0
Inv. Purchases-$3-$7-$7-$37
Inv. Sales/Matur.$2$24$43$56
Other Inv. Act.$3-$11-$3-$0
Investing Cash Flow-$2-$101$32$18
Financing Activities
Debt Repay.-$3$54-$1-$7
Stock Issued$0$0$0$0
Stock Repurch.$0-$0-$3-$5
Dividends Paid$0$0$0$0
Other Fin. Act.-$1-$3-$0-$3
Financing Cash Flow-$4$51-$5-$15
Forex Effect-$0-$4$1$2
Net Chg. in Cash$2-$34$32$6
Supplemental Information
Beg. Cash$57$112$80$74
End Cash$59$78$112$80
Free Cash Flow$7-$5-$0$0